Shopping Cart
Remove All
Your shopping cart is currently empty
NOTA-FAPI
🥰Excellent
Catalog No. T69660Cas No. 2374782-03-1
Alias NTFAPI, NOTA-FAPI-04
NOTA-FAPI is a fibroblast activation protein (FAP) inhibitor and structural analogue of FAPI-4. NOTA-FAPI-4 serves as a diagnostic and therapeutic tool for diseases characterized by FAP overexpression, including its application as a positron emission tomography (PET) tracer for noninvasive imaging of FAP-associated pathological conditions and monitoring of therapeutic responses.
NOTA-FAPI
🥰Excellent
Purity: 99.748%
Catalog No. T69660Alias NTFAPI, NOTA-FAPI-04Cas No. 2374782-03-1
NOTA-FAPI is a fibroblast activation protein (FAP) inhibitor and structural analogue of FAPI-4. NOTA-FAPI-4 serves as a diagnostic and therapeutic tool for diseases characterized by FAP overexpression, including its application as a positron emission tomography (PET) tracer for noninvasive imaging of FAP-associated pathological conditions and monitoring of therapeutic responses.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $289 | - | In Stock | |
| 5 mg | $787 | - | In Stock | |
| 10 mg | $1,360 | - | In Stock | |
| 25 mg | $1,980 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.748%
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
| Description | NOTA-FAPI is a fibroblast activation protein (FAP) inhibitor and structural analogue of FAPI-4. NOTA-FAPI-4 serves as a diagnostic and therapeutic tool for diseases characterized by FAP overexpression, including its application as a positron emission tomography (PET) tracer for noninvasive imaging of FAP-associated pathological conditions and monitoring of therapeutic responses. |
| In vitro | In U87MG cells, Al18F-NOTA-FAPI-4 exhibited the highest uptake rate (2.13±0.17 AD%) at 10 minutes, and this uptake could be blocked by unlabeled precursors. The IC50 value of NOTA-FAPI-4 was 1.73±0.93 nM, indicating its high affinity for FAP [1]. |
| In vivo | In KM mice, Al18F-NOTA-FAPI demonstrated rapid renal clearance and low uptake in most normal organs. In U87MG tumor-bearing mice, the uptake in the tumor region was relatively high (35.29±1.00%ID/g), with a 33.72% decrease in uptake observed between 1 hour and 4 hours [1]. |
| Synonyms | NTFAPI, NOTA-FAPI-04 |
| Molecular Weight | 771.81 |
| Formula | C36H47F2N9O8 |
| Cas No. | 2374782-03-1 |
| Smiles | C(NCC(=O)N1[C@H](C#N)CC(F)(F)C1)(=O)C=2C3=C(C=CC(OCCCN4CCN(C(CN5CCN(CC(O)=O)CCN(CC(O)=O)CC5)=O)CC4)=C3)N=CC2 |
| Color | Yellow |
| Appearance | Solid |
Storage & Solubility Information
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (103.65 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (4.28 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy NOTA-FAPI | purchase NOTA-FAPI | NOTA-FAPI cost | order NOTA-FAPI | NOTA-FAPI chemical structure | NOTA-FAPI in vivo | NOTA-FAPI in vitro | NOTA-FAPI formula | NOTA-FAPI molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.